The Patent Finder
NE

Neurmedix, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

9 patents currently held

3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Apr 2029. from the record

Of the 3 now held by other companies, 2 name Biovie Inc. as their current owner, and 1 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
7
Ending by 2030
Apr 2029
Next term end
4
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 20, 2027
    The maintenance fee for Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related COMPOUNDS-2 (US 9,163,059) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.
  • 1 fee due Oct 19, 2027
    The maintenance fee for Methods of Preparing Pharmaceutical Solid State Forms (US 9,314,471) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 9 of 9

PatentTitleStatusExpiresConfidence
US 9,850,271Crystalline solvate forms of a pharmaceutical
In force
 · High confidence
In forceHigh confidence
US 9,877,972Treatment Methods Using Pharmaceutical Solid State Forms
In force
 · High confidence
In forceHigh confidence
US 10,995,112Crystalline Solvate Forms of a Pharmaceutical
In force
 · High confidence
In forceHigh confidence
US 9,163,059Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related COMPOUNDS-2
In force
 · High confidence
In forceHigh confidence
US 9,314,471Methods of Preparing Pharmaceutical Solid State Forms
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 8,252,947Solid State Forms of a Pharmaceutical
In force
 · High confidence
In forceHigh confidence
US 8,309,746Methods for Preparing 17-Alkynyl-7-Hydroxy Steroids and Related Compounds
In force
 · High confidence
In forceHigh confidence
US 8,354,396Drug Identification and Treatment Method
In force
 · High confidence
In forceHigh confidence
US 8,518,922Pharmaceutical Solid State Forms
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 9: 3 patents in force now held by others · 30 patents ended · 52 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited